Latest Sales Growth News

Advanced Braking Technology has appointed CEO Andrew Booth to the Board as Managing Director, signaling confidence in his leadership amid ongoing growth.

dorsaVi has inked a five-year sales agreement with Select Medical, opening access to over 1,900 US outpatient physical therapy centers for its FDA-approved motion analysis products. This follows a successful 18-month pilot validating clinical benefits in athlete rehabilitation.

Briscoe Group Limited reported a near-flat half-year sales performance with a modest decline in net profit, while advancing key strategic investments including a new distribution centre. The company declared a 10-cent interim dividend amid cautious economic outlook.

The Calmer Co. reports a significant operational turnaround in H2 FY25, with sales momentum building through July and August, driven by cost reductions and new product launches in the US market.

Brambles Limited has clarified that its full-year 2025 earnings aligned closely with prior guidance and market expectations, with no material surprises. The company’s robust FY26 outlook, including increased dividends and a significant share buy-back, underpinned positive investor sentiment.

Collins Foods delivered record $1.5 billion revenue in FY25, pivoting to focus on KFC growth in Australia and Germany while exiting Taco Bell. Despite impairments and wage remediation costs, the company targets strong profit growth in FY26.

Collins Foods has reported a robust 6.7% increase in total sales for the first 18 weeks of FY26, driven by strong same-store sales growth in Australia, the Netherlands, and Germany. The company reaffirms its optimistic profit guidance amid ongoing expansion and operational improvements.

Eneco Refresh Limited has appointed Christerpher Conyers as CEO following his instrumental role in returning the company to profitability. His leadership marks a new chapter focused on sustaining growth and operational efficiency.

Atomos Ltd reported a 9% revenue decline in FY25, impacted by US tariffs and weak sales of new products, but has aggressively cut costs and revamped its strategy to fuel growth in FY26.

Pure Foods Tasmania has completed a strongly oversubscribed $1.76 million capital raise and reported improved preliminary FY25 results, signaling progress in its turnaround strategy.

PT Aneka Tambang Tbk (ANTAM) posted a 7% increase in sales to Rp23.19 trillion in the first half of 2024, driven by strong domestic gold sales, and reported a net profit of Rp1.51 trillion. The company also completed significant divestments, retaining control of SDA while divesting majority ownership in FHT.

Botanix Pharmaceuticals posted a sharp revenue increase driven by its new hyperhidrosis treatment Sofdra, yet reported a substantial net loss reflecting heavy investment in commercialisation. The company’s strong cash position underpins its path to profitability.